SEC Form 4 · accession 0001209191-15-006342
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey W Sherman
Officer — EVP and Chief Medical Officer
Period of report
Dec 8, 2014
Accepted (ET)
Jan 26, 2015 · 8:51 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Dec 8, 2014 | M | 8,208 | — | A | 86,992 | D | |
| Ordinary Shares | Dec 8, 2014 | F | 2,656 | $12.99 | D | 84,336 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Dec 8, 2014 | M | 8,208 | D | — | — | Ordinary Shares | 16,416 | 8,208 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2Includes 4,485 ordinary shares of the Issuer acquired by the reporting person in December 2014 pursuant to an employee stock purchase program
- F3On December 8, 2011, the reporting person was granted 32,832 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.